Connect with us

Hi, what are you looking for?

THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle



DEA Lists All ‘Marihuana’ extracts as Schedule I Drugs

On December 21, the Federal Register included a new item entitled 21 CFR Part 1308, which lists all ‘marihuana’ extracts as Schedule I drugs, including cannabidiol (CBD), which has legitimate, able-to-be-proven medicinal benefits. Oh, and not to mention, it’s NON-psychoactive, so it does NOT get users high.

Just to clarify, there are three criteria listed on the DEA’s website that qualify a drug for the Schedule 1 list: the drug must have a high potential for abuse, the drug has no currently accepted medical use in treatment in the United States, there is a lack of safety associated with use of the drug even under medical supervision.

Now, have a look at this. In an article entitled “5 Must-Know Facts About Canabidiol (CBD)” found on, there are seven medical properties of CBD listed: antiemetic (reduced nausea and vomiting), anticonvulsant, antipsychotic, anti-inflammatory, anti-oxidant, anti-tumoral/anti-cancer, anxiolytic/anti-depressant.

Furthermore, the U.S. Cancer Institute, which is part of the U.S. Department of Health, states on their website, “another active cannabinoid is CBD, which may relieve pain, lower inflammation, and decrease anxiety without causing the ‘high.’” The site goes on to say, “cannabinoids may have benefits in treating the symptoms of cancer or the side effects of cancer therapies.”

Seeing the discrepancy yet?

Like you, I too am wondering why the DEA would blatantly ignore the criteria they created, in order to place CBD, a ‘drug’ that has many apparent medical benefits under a category of drugs that are supposed to have “no currently accepted medical use in treatment.” So CBD is now alongside drugs peyote, meth, and heroine.

Supposedly, the new regulation is supposed to help the DEA track medical benefits of each individual extraction from the genus Cannabis. However, many of the marijuana industry leaders fear the classification is the first shot of many to come from the new presidential administration, in order to diminish and reverse the progress made in legalizing the industry.

And just like that, it all comes back to Trump.

Comment Template

You May Also Like


More than 10 million people have signed up for X in December, CEO says, The Chief Executive Officer of X, Linda Yaccarino, stated in...


Three persons acquainted with the topic have stated that Nvidia (NVDA.O) is in advanced discussions with the Malaysian conglomerate YTL (YTLS.KL) for a data...


Apple will move essential iPad engineering resources to Vietnam- Nikkei. Apple is moving its iPad product development resources to Vietnam, according to a Friday...


As a result of sluggish business expenditure and intense competition, chipmaker Broadcom (AVGO.O) forecasted yearly revenue that was lower than what Wall Street had...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.